UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Statement of Cash Flows
Net income	$ 2,735	$ 2,789
Depreciation	155	169
Amortization	639	651
(Gain) loss on investments
Provision for (recovery of) losses on accounts receivable	0	7
(Gain)/Loss on disposal of assets	0
Deferred income taxes	(177)	(251)
Stock-based compensation expense	7	20
Accounts receivable - trade	(958)	(1,227)
Accrued interest and other receivables	(171)	(49)
Inventories	(82)	229
Prepaid expenses and other current assets	22	(70)
Accounts payable	184	309
Accrued expenses	390	882
Deferred revenue	(25)	(25)
Other liability
Total adjustments	(16)	646
Net cash provided by operating activities	2,719	3,434
Capital expenditures for property and equipment	(52)	(61)
Capital expenditures for intangible assets		(1)
Net cash used in investing activities	(52)	(62)
Proceeds from issuance of common stock - options	340	585
Common stock purchased and retired
Payment of taxes for exchange of stock options	(90)
Tax benefit attributable to exercise of stock options	175	55
Repayment of notes payable	(969)	(2,464)
Payment of dividends
Net cash provided by (used in) financing activities	(544)	(1,824)
Effect of exchange rate changes on cash	(124)	76
NET INCREASE IN CASH	1,999	1,624
CASH AT BEGINNING OF PERIOD	8,871	6,534
CASH AT END OF PERIOD	10,870	8,159
Cash paid during the period for income taxes
Cash paid during the period for interest	$ 122	$ 189